<DOC>
	<DOC>NCT00364091</DOC>
	<brief_summary>The purpose of this summary is to evaluate the efficacy and safety of R89674 0.025% ophthalmic solution compared with placebo or an active control in subjects with seasonal allergic conjunctivitis</brief_summary>
	<brief_title>Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>history of positive diagnostic test for ragweed within the past 2 years; positive bilateral response to ragweed as induced by conjunctival allergen challenge ocular infection; history of retinal detachment, diabetic neuropathy, or any progressive retinal disease; moderate to severe asthma; dry eye syndrome; history of severe, unstable, or uncontrolled cardiovascular, pulmonary, hepatic, renal or autoimmune disease; pregnancy or lactation</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>allergic conjunctivitis, ophthalmology, multicenter, controlled</keyword>
</DOC>